A Randomized, Placebo-Controlled Trial Evaluating the Safety and Efficacy of Adding Omarigliptin to Antihyperglycemic Therapies in Japanese Patients with Type 2 Diabetes and Inadequate Glycemic Control

INTRODUCTION: Daily dipeptidyl peptidase-4 (DPP-4) inhibitors are commonly used with other orally administered antihyperglycemic agents (AHA), as combination therapy, to treat Japanese patients with type 2 diabetes. When combination therapy is indicated, use of a once-weekly (q.w.) orally administer...

Descripción completa

Detalles Bibliográficos
Autores principales: Gantz, Ira, Okamoto, Taro, Ito, Yuka, Sato, Asako, Okuyama, Kotoba, O’Neill, Edward A., Engel, Samuel S., Lai, Eseng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2017
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5544607/
https://www.ncbi.nlm.nih.gov/pubmed/28589493
http://dx.doi.org/10.1007/s13300-017-0270-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5544607/
https://www.ncbi.nlm.nih.gov/pubmed/28589493
http://dx.doi.org/10.1007/s13300-017-0270-7

Ejemplares similares